Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Series B: Frontiers in Genomics Research NEW GENRE Audio English-Spanish

• Original Volume One: Genomics Orientations for Personalized Medicine

On Amazon.com since 11/23/2015

http://www.amazon.com/dp/B018DHBUO6

• NEW GENRE Volume One: Genomics Orientations for Personalized Medicine 

https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-b-frontiers-in-genomics-research/new-genre-volume-one-genomics-orientations-for-personalized-medicine-series-b-volume-1/

PART A: The eTOCs in Spanish in Audio format

PART B: The eTOCs in Bi-lingual format: Spanish and English in Text format

PART C: The Editorials of the original e-Books in English in Audio format

 

• Original Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology

On Amazon.com since 12/28/2019

https://www.amazon.com/dp/B08385KF87

• New Genre Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology 

https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-b-frontiers-in-genomics-research/new-genre-volume-two-latest-in-genomics-methodologies-for-therapeutics-gene-editing-ngs-and-bioinformatics-simulations-and-the-genome-ontology-series-b-volume-2/

PART A:

A.1: The eTOCs in Spanish in Audio format AND

A.2: The eTOCs in Bi-lingual format: Spanish and English in Text format

PART B: The graphical results of Machine Learning (ML), Deep Learning (DL) and Natural Language Processing (NLP) algorithms AND the Domain Knowledge Expert (DKE) interpretation of the results in Text format – IS ISSUED AS A STANDALONE VOLUME: Volume Three  NEW GENRE Volume Three in Series B.

PART C: The Editorials of the original e-Books in English in Audio format

• Volume Three did not exist in the Original BioMed e-Series, Series B: Frontiers in Genomics Research

• During production it was known as PART B of Genomics, Volume Two to be published in the NEW GENRE e-Series B. It was thought to be included in Volume Two. Due to number of plots involved, a standalone volume for NLP Results and Interpretation was born, aka, Volume Three.

• NEW GENRE Volume Three: Results of Medical Text Analysis with Natural Language Processing (NLP).  It is known in 2022, as Genomics Volume Three in NEW GENRE Series B: Frontiers in Genomics Research

https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-b-frontiers-in-genomics-research/genomics-volume-2-results-of-medical-text-analysis-with-natural-language-processing-nlp/

 

This page has the following sub pages.

• NEW GENRE Volume One: Genomics Orientations for Personalized Medicine – Series B, Volume 1
• NEW GENRE Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology – Series B, Volume 2
• NEW GENRE Genomics Volume Three, Results of Medical Text Analysis with Natural Language Processing (NLP) – Series B, Volume 3